NovaBay Pharma (NBY) Balance Sheet

Click line-items for a historical chart and %

ASSETS
Cash and cash equivalents	9.43M
Short-term investments
Accounts receivable	2.08M
Prepaid expenses and other current assets	1.83M
Total current assets	14.42M
Property and equipment, net	282K
Other assets	439K
TOTAL ASSETS	15.14M
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	387K
Accrued liabilities
Equipment loan
Deferred revenue	1.46M
Total current liabilities	3.73M
Deferred revenues - non-current	1.91M
Deferred rent	248K
Total liabilities	8.42M
Stockholders' Equity:
Common stock, $0.01 par value; 65,000 shares authorized at June 30, 2011 and December 31, 2010; 23,484 and 23,392 issued and outstanding at June 30, 2011 and December 31, 2010, respectively	149K
Additional paid-in capital	108.59M
Accumulated other comprehensive loss
Accumulated deficit during development stage
Total stockholders' equity	6.72M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	15.14M

Entities mentioned with NBY